Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents
暂无分享，去创建一个
A. Stamatoullas | P. Fenaux | L. Adès | J. Delaunay | N. Vey | R. Itzykson | R. Sapena | O. Beyne-Rauzy | F. Dreyfus | A. Ferrant | E. Raffoux | V. Coiteux | S. Chèze | B. Choufi | C. Kelaidi | S. Park | C. Ravoet | M. Gourin | L. Aljassem | M. Escoffre-barbe